The interaction of a new anti-tumour drug, KAR-2 with calmodulin

British Journal of Pharmacology

Volumn 121, Issue 5, 1997, Pages 955-962

  Orosz, F ^a   Vertessy B G ^a   Salerno, C ^b   Crifo, C ^b   Capuozzo, E ^b   Ovadi J ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Bis indols; Calmodulin antagonism; Vinblastine; Vinca alkaloids; Vincristine

Indexed keywords

ANTINEOPLASTIC AGENT; CALCIUM ION; CALMODULIN; FLUORESCENT DYE; KAR 2; TRIFLUOPERAZINE; UNCLASSIFIED DRUG; VINBLASTINE; VINBLASTINE DERIVATIVE;

ANISOTROPY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING AFFINITY; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CIRCULAR DICHROISM; CONTROLLED STUDY; DISSOCIATION CONSTANT; DRUG POTENCY; DRUG PROTEIN BINDING; ENZYME KINETICS; FLUORESCENCE; HUMAN; HUMAN CELL; IMMUNOLOGICAL PROCEDURES; MICROTUBULE; NEUTROPHIL; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CALCIUM; CALMODULIN; CATTLE; CIRCULAR DICHROISM; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN G; ISOENZYMES; NEUTROPHILS; PHOSPHOFRUCTOKINASE-1; PROTEIN BINDING; SPECTROMETRY, FLUORESCENCE; SPECTROPHOTOMETRY, ULTRAVIOLET; TRIFLUOPERAZINE; VINBLASTINE;

EID: 0030996334     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701190     Document Type: Article

References (47)

1. ASANO, M., SUZUKI, Y. & HIDAKA, J. (1982). Effects of various calmodulin antagonists on contraction of rabbit aortic strips. J. Pharmacol. Exp. Ther., 220, 191-196.
2. BERSHADSKY, A.D. & VASILIEV, J.M. (1988). Cytoskeleton. New York: Plenum Press.
3. DE BRABANDER, M., NUYDENS, R., GEUENS, G., MOEREMANS, M., DE MEY, J. & HOPKINS, C. (1980). Nanovid ultramicroscopy: a new non-destructive approach providing new insights in subcellular motility. In Microtubules and Microtubule Inhibitors. ed. De Brabander, M. & De Mey, J. pp. 187-196. Amsterdam, New York: Elsevier.
4. ENGWALL, E. (1980). Enzyme Immunoassay ELISA and EMIT. Methods Enzymol., 70, 419-439.
5. FELLOUS, A., OHAYON, R., VACASSIN, T., BINET, S., LATASTE, H., KRIKORIAN, A., COUZINIER, J.C. & MEININGER, V. (1989). Biochemical effects of navelbine on tubulin and associated proteins. Seminars in Oncology, 16 (suppl. 4), 9-14.
6. FERRANTE, A. & THONG, Y.H. (1980). Optional conditions for simultaneous purification of mononuclear and polymorphonuclear leukocytes from human peripheral blood by the hypaque-ficoll method. J. Immunol. Methods., 36, 109-117.
7. 2+-transport ATPase. Mol. Pharmacol., 22, 413-420.
8. 2+-induced hydrophobic site on calmodulin: application for purification of calmodulin by phenyl-sepharose affinity chromatography. Biochem. Biophys. Res. Commun., 104, 830-836.
9. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem., 260, 3440-3450.
10. HESTERBERG, L.K. & LEE, J.C. (1982). Self-association of rabbit muscle phosphofructokinase: effects of ligands. Biochemistry, 21, 216-222.
11. HIDAKA, H., SASAKI, Y., TANAKA, T., ENDO, T., OHNO, S., FUJII, Y. & NAGATA, T. (1981). N-(6-aminohexyl)-5-chloror-1-naphtalenesulfonamide, a calmodulin antagonist inhibitors cell proliferation. Proc. Natl. Acad. Sci. U.S.A., 78, 4354-4357.
12. HIMES, R.H., KERSEY, R.N., HELLER-BETTINGER, I. & SAMSON, F.E. (1976). Action of the Vinca alkaloids vincristine, vinblastine, and desacetyl vinblastine amide on microtubules in vitro. Cancer Res., 36, 3798-3802.
13. KAWASAKI, H., ITOH, S., KASAI, H., MITSUI, Y., IITAKA, Y., NAKANASHI, M. & OKUYAMA, T. (1985). Crystallization of calcium-calmodulin-trifluoperazine complex and an attempt at crystallizing calcium-free calmodulin. J. Biochem. (Tokyo), 97, 1815-1818.
14. LAEMMLI, U.K. (1970). Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature, 227, 680-688.
15. LAGAST, H., LEW, P.D. & WALDVOGEL, F.A. (1984). Adenosine triphosphate-dependent calcium pump in the plasma membrane of guinea pig and human neutrophils. J. Clin. Invent., 73, 107-115.
16. LANDRY, Y., AMELLAL, M. & RUCKSTUHL, M. (1981). Can calmodulin inhibitors be used to probe calmodulin effects? Biochem. Pharmacol., 30, 2031-2032.
17. LANGLOIS, N., GUERITTE, F. & LANGLOIS, Y. (1976). Application of a modification of the Polanowski reaction to the synthesis of Vinblastine-type alkaloid. J. Am. Chem. Soc., 22, 7017-7024.
18. LEHOTZKY, A., TELEGDI, M., LILIOM, K. & OVÁDI, J. (1993). Interaction of phosphofructokinase with tubulin and microtubule: quantitative evaluation of the mutual effects. J. Biol. Chem., 268, 10888-10894.
19. LEVIN, R.M. & WEISS, B. (1980). Inhibition by trifluoperazine of calmodulin-induced activation of ATPase activity of rat erythrocyte. Neuropharmacology, 19, 169-174.
20. LILIOM, K., LEHOTZKY, A., MOLNÁR, A. & OVÁDI, J. (1995). Characterization of tubulin - drug interactions by ELISA. Anal. Biochem., 228, 18-27.
21. LILIOM, K., OROSZ, F., HORVÁTH, L. & OVÁDI, J. (1991). Quantitative evaluation of indirect ELISA. Effect of calmodulin antagonists on antibody binding to calmodulin. J. Immunol. Methods, 143, 119-125.
22. MAJANDER, A. & WIKSTRÖM, M. (1989). The plasma membrane potential of human neutrophils. Role of ion channels and the sodium/potassium pump. Biochim. Biophys. Acta, 980, 139-145.
23. MAYR, G.W. (1987). Interaction of calmodulin with phosphofructokinase: binding studies and evaluation of enzymatic and physicochemical changes. Methods Enzymol., 139, 745-763.
24. MCINTOSH-KOONCE, R. (1989). Mitosis. Science (Wash, DC), 246, 622-628.
25. MIGLIACCIO, A., ROTONDI, A. & AURICCHI, F. (1984). Calmodulin-stimulated phosphorylation of 17 beta-estradiol receptor in tyrosine. Proc. Natl. Acad. Sci. U.S.A., 81, 5921-5925.
26. MOLNÁR, A., LILIOM, K., OROSZ, F., VÉRTESSY, B.G. & OVÁDI, J. (1995). Anti-calmodulin potency of indol alkaloids in in vitro systems. Eur. J. Pharmacol., 291, 73-82.
27. NAIRN, A.C. & PERRY, S.V. (1979). Calmodulin and myosin light-chain kinase of rabbit fast skeletal muscle. Biochem. J., 179, 89-97.
28. NEWTON, D.L., BURKE, T.R., RICE, K.C. & KLEE, B. (1983). Calcium ion dependent covalent modification of calmodulin with norchlorpromazine isothiocyanate. Biochemistry, 22, 5472-5476.
29. OROSZ, F., CHRISTOVA, T.Y. & OVÁDI, J. (1988a). Functional in vitro test of calmodulin antagonism: Effect of drugs on interaction between calmodulin and glycolytic enzymes. Mol. Pharmacol., 33, 678-682.
30. OROSZ, K., CHRISTOVA, T.Y. & OVÁDI, J. (1988b). Modulation of phosphofructokinase action by macromolecular interactions. Quantitative analysis of phosphofructokinase - aldolase - calmodulin interacting system. Biochim. Biophys. Acta, 957, 293-300.
31. OROSZ, F., KOVÁCS, J., LÖW, P., VÉRTESSY, B.G., URBANYI, Z., ÁCS, T., KEVE, T. & OVADI, J. (1997). Interaction of a new bisindole derivative, KAR-2 with tubulin and its antimitotic activity. Br. J. Pharmacol., (MS 96 - 1560).
32. OROSZ, F., LILIOM, K., BARKHUDARYAN, N., HORVÁTH, L. & OVÁDI, J. (1992). Effects of calmodulin antagonists on antibody binding to calmodulin. Distinct conformers of calmodulin induced by the binding of drugs. Biochem., 284, 803-808.
33. OROSZ, F., TELEGDI, M., LILIOM, K., SOLTI, M., KORBONITS, D. & OVÁDI, J. (1990). Dissimilar mechanisms of action of anti-calmodulin drugs: quantitative analysis. Mol. Pharmacol., 38, 910-916.
34. OVÁDI, J. (1989). Effects of drugs on calmodulin-mediated enzymatic actions. A review. Prog. Drug Res., 33, 353-395.
35. OVÁDI, J., MOHAMED OSMAN, I.R. & BATKE, J. (1982). Local conformational changes induced by successive nicotinamide binding to dissociable tetrameric D-glyceraldehyde-3-phosphate dehydrogenase: quantitative analysis of a two step dissociation process. Biochemistry, 21, 6375-6382.
36. OWELLEN, R.J., HARTKE, C.A., DICKERSON, R.M. & HAINES, F.O. (1976). Inhibition of tubulin-microtubule polymerization by drugs of the vinca alkaloid class. Cancer Res., 36, 1499-1502.
37. 2+)-ATPase and its antagonism by phenothiazines. Molec. Pharmacol., 18, 253-258.
38. 1 and mitosis. EMBO J., 8, 73-82.
39. SEEMAN, P. (1972). The membrane actions of anesthetics and tranquilizers. Pharmacol. Rev., 24, 583-633.
40. 2+/calmodulin. Biochem. Biophys. Res. Commun., 111, 652-658.
41. STEVENSON, G.T. & DORRINGTON, K.J. (1970). The recombination of dimers of immunoglobulin peptide chains. Biochem. J., 118, 703-712.
42. 2+ and membrane in lymphocytes. Nature, 295, 68-70.
43. 2+-calmodulin-drug and apocalmodulin-drug complexes. PROTEINS: Structure, Function and Genetics, (in press).
44. WALLACE, R.W. & CHEUNG, W.Y. (1979). Calmodulin. Production of an antibody in rabbit and development of a radioimmunoassay. J. Biol. Chem., 254, 6564-6571.
45. WATANABE, K. & WEST, W.L. (1982). Calmodulin, activated cyclic nucleotide phosphodiesterase, microtubules and vinca alkaloids. Fedn. Proc., 41, 2292-2299.
46. 2+-dependent regulatory proteins of 3′:5′-cyclic nucleotide phosphodiesterase and actomyosin ATPase. J. Biol. Chem., 251, 4501-4513.
47. YASIN, R., HUGHES, B.P. & PARKER, J.A. (1973). The effect of vincristine on the calcium transport and phospholipid composition of rat skeletal muscle microsomes. Lab. Invest., 29, 207-215.